![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » U.S. Appeals Court Finds Astra’s Seroquel XR Patent Infringed
U.S. Appeals Court Finds Astra’s Seroquel XR Patent Infringed
February 15, 2013
A U.S. appeals court upheld a lower court ruling that found the formulation patent for AstraZeneca’s anti-psychotic drug Seroquel XR was valid and had been infringed by Mylan and other companies seeking to sell generic versions of the medicine.
Reuters
Reuters
Upcoming Events
-
21Oct